568 related articles for article (PubMed ID: 30715139)
61. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
62. Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center.
Dashevsky BZ; Gallagher KM; Grabenstetter A; Cordeiro PG; Dogan A; Morris EA; Horwitz SM; Sutton EJ
Breast J; 2019 Jan; 25(1):69-74. PubMed ID: 30521149
[TBL] [Abstract][Full Text] [Related]
63. Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations.
Riis M; Csanaky G; Lehne G; Tangerud A
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236698
[TBL] [Abstract][Full Text] [Related]
64. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract][Full Text] [Related]
65. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Why Must We Learn About It?
de Oliveira Sermoud LMC; Romano S; Chveid M; da Silva Amorim GL
J Glob Oncol; 2019 Aug; 5():1-5. PubMed ID: 31454283
[TBL] [Abstract][Full Text] [Related]
66. How I treat breast implant-associated anaplastic large cell lymphoma.
Mehta-Shah N; Clemens MW; Horwitz SM
Blood; 2018 Nov; 132(18):1889-1898. PubMed ID: 30209119
[TBL] [Abstract][Full Text] [Related]
67. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Rondón-Lagos M; Rangel N; Camargo-Villalba G; Forero-Castro M
Eur J Surg Oncol; 2021 May; 47(5):942-951. PubMed ID: 33158639
[TBL] [Abstract][Full Text] [Related]
68. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
[TBL] [Abstract][Full Text] [Related]
69. Breast Implant-associated Anaplastic Large Cell Lymphoma: An Evidence-based Systematic Review.
DeCoster RC; Lynch EB; Bonaroti AR; Webster JM; Butterfield TA; Evers BM; Vasconez HC; Clemens MW
Ann Surg; 2021 Mar; 273(3):449-458. PubMed ID: 33234792
[TBL] [Abstract][Full Text] [Related]
70. A Different Perspective on Breast Implant Surface Texturization and Anaplastic Large Cell Lymphoma (ALCL).
Brown T; Harvie F; Stewart S
Aesthet Surg J; 2019 Jan; 39(1):56-63. PubMed ID: 29659699
[TBL] [Abstract][Full Text] [Related]
71. Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Perry L; Radzevich J; Kelter D; Gott M; Slotman G; Kulkarni N; Gundlapalli V
Am Surg; 2022 Aug; 88(8):2065-2067. PubMed ID: 32931319
[No Abstract] [Full Text] [Related]
72. Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
Medeiros LJ; Marques-Piubelli ML; Sangiorgio VFI; Ruiz-Cordero R; Vega F; Feldman AL; Chapman JR; Clemens MW; Hunt KK; Evans MG; Khoo C; Lade S; Silberman M; Morkowski J; Pina EM; Mills DC; Bates CM; Magno WB; Sohani AR; Sieling BA; O'Donoghue JM; Bacon CM; Patani N; Televantou D; Turner SD; Johnson L; MacNeill F; Wotherspoon AC; Iyer SP; Malpica LE; Patel KP; Xu J; Miranda RN
Mod Pathol; 2021 Dec; 34(12):2154-2167. PubMed ID: 34226673
[TBL] [Abstract][Full Text] [Related]
73. Considerations on the Demography of BIA-ALCL in European Countries Based on an E(A)SAPS Survey.
Stark B; Magnéli M; van Heijningen I; Parreira C; Bösch U; Rouif M; Halle M
Aesthetic Plast Surg; 2021 Dec; 45(6):2639-2644. PubMed ID: 34286385
[TBL] [Abstract][Full Text] [Related]
74. Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.
Vorstenbosch J; Ghione P; Plitas G; Horwitz S; Kim M; Cordeiro P; Nelson J; McCarthy C
Ann Surg Oncol; 2024 Mar; 31(3):2032-2040. PubMed ID: 38102324
[TBL] [Abstract][Full Text] [Related]
75. Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
Reisman NR
Aesthet Surg J; 2021 Nov; 41(12):NP1950. PubMed ID: 33939793
[No Abstract] [Full Text] [Related]
76. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
77. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
78. Successful Treatment of a Patient With Breast Implant-Associated Anaplastic Large Cell Lymphoma With Local Residual Disease: A Case Report.
Di Napoli A; Firmani G; Sorotos M; Lopez G; Noccioli N; De Sanctis V; Tafuri A; Santanelli di Pompeo F
Ann Plast Surg; 2022 Feb; 88(2):152-156. PubMed ID: 34711728
[TBL] [Abstract][Full Text] [Related]
79. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
80. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
